Breakthrough test could end dangerous misdiagnosis of brain disease
NCT ID NCT07166744
Summary
This study aims to develop a better test to tell the difference between two common brain diseases: Lewy body dementia and Alzheimer's. Researchers will test a new method that looks for a specific, harmful protein in spinal fluid from 286 people who already show signs of one of these conditions. The goal is to create a more reliable diagnostic tool to prevent patients from receiving incorrect and potentially harmful treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE (AD) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.